市场调查报告书
商品编码
1541088
2024-2032 年按技术(三重四极桿、四极桿 TOF、FTMS、四极桿、飞行时间、离子阱等)、应用和区域分類的质谱市场报告Mass Spectrometry Market Report by Technology (Triple Quadrupole, Quadrupole TOF, FTMS, Quadrupole, Time-of-Flight, ION Trap, and Others), Application, and Region 2024-2032 |
2023 年,全球质谱IMARC Group规模达到 65 亿美元。最近的技术进步、严格的品质控制监管政策、对个人化医疗的日益关注以及公共和私营部门研发(R&D)资金的增加是推动市场的一些主要因素。
质谱法是指用于测量离子质荷比的分析技术。它包括气相层析质谱 (GC-MS)、基质辅助雷射解吸/电离 (MALDI) 和液相层析质谱 (LC-MS)。质谱分析具有许多特性,例如高灵敏度、特异性和宽动态范围。它广泛应用于药物发现、环境监测、法医学、食品安全、临床诊断、蛋白质体学、石油探勘和材料科学。质谱分析提供高通量能力、分析的多功能性以及与其他多维分析技术的兼容性。
公共和私营部门的研发(R&D)资金不断增加,为购买先进的质谱系统提供了财政支持,推动了市场的成长。此外,人们对环境污染的日益关注需要对空气和水样本进行分析,这也是另一个促进成长的因素。此外,法医学的不断发展,加上刑事调查中对物质分析的迫切需求,正在促进市场的成长。除此之外,新兴的代谢组学领域(涉及生物样本中代谢物的详细分析)正在促进市场成长。除此之外,在各种科学探索的学术研究中采用质谱分析正在促进市场成长。此外,技术融合,即质谱法与色谱法等其他技术相结合,从而扩大了其适用性,正在加强市场成长。
最近的技术进步
技术进步的激增极大地促进了质谱市场的扩张。尖端的改进,例如更高的灵敏度、更好的准确性和快速的通量,使这些仪器在现代实验室中不可或缺。此外,技术进步正在扩展质谱仪器的能力,以包括对日益复杂的样品的分析。此外,高分辨率质谱和串联质谱等最新创新提供了前所未有的细节水平和分析深度,支持了市场的成长。此外,即时监控功能的结合,允许立即收集和解释资料,正在加强市场成长。此外,质谱设备的小型化导致了可用于现场分析的便携式设备的诞生,有利于市场的成长。
实施严格的品质管制监管政策
製药和食品安全等行业品质控制的监管要求正在推动质谱市场的成长。监管机构引入严格的标准促使公司依赖质谱法来检测杂质、确保产品品质和验证工艺,因为质谱法具有高精度和高灵敏度。此外,质谱可确保化合物符合纯度标准,并在极低浓度下检测到污染物。此外,食品业广泛利用技术来确保不含农药、毒素和其他污染物,这有利于市场成长。此外,这些监管强制要求使得质谱分析不仅是一种选择,而且是产品开发和製造过程中品质保证的必需品。
对个人化医疗的日益关注
对个人化医疗的日益重视是刺激质谱市场的另一个关键因素。医疗保健越来越适合个别患者,从而对详细的分子和遗传资讯提出了更高的需求。质谱分析提供了在分子层面分析生物标记、代谢物和蛋白质的能力,从而在蛋白质体学和基因组学研究中发挥重要作用。这些见解对于了解个人健康状况、预测疾病易感性并相应调整治疗方案至关重要。此外,个人化医疗的兴起正在推动医疗保健提供者和研究机构投资质谱技术,以满足对精确、患者特定资料的需求。因此,对个人化医疗保健的关注不仅促进了质谱在现有市场的应用,而且还开创了其进入医学科学新领域的先河。
The global mass spectrometry market size reached US$ 6.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032. The recent technological advancements, imposition of strict regulatory policies for quality control, growing focus on personalized medicine, and escalating funding for research and development (R&D) in both public and private sector are some of the major factors propelling the market.
Mass spectrometry refers to an analytical technique used to measure the mass-to-charge ratio of ions. It includes gas chromatography-mass spectrometry (GC-MS), matrix-assisted laser desorption/ionization (MALDI), and liquid chromatography-mass spectrometry (LC-MS). Mass spectrometry offers numerous features, such as high sensitivity, specificity, and a broad dynamic range. It is widely used in drug discovery, environmental monitoring, forensics, food safety, clinical diagnostics, proteomics, petroleum exploration, and materials science. Mass spectrometry offers high-throughput capabilities, versatility in analysis, and compatibility with other techniques for multidimensional analysis.
The escalating funding for research and development (R&D) in both public and private sectors, which is providing financial support for acquiring advanced mass spectrometry systems is propelling the market growth. Additionally, the growing concerns about environmental pollution that are necessitating the analysis of air and water samples are acting as another growth-inducing factor. Furthermore, the rising expansion of forensic science, coupled with the urgent requirement for substance analysis in criminal investigations, is contributing to the market growth. Besides this, the burgeoning field of metabolomics, which involves the detailed analysis of metabolites in biological samples, is bolstering the market growth. Apart from this, the adoption of mass spectrometry in academic research for various scientific explorations is catalyzing the market growth. Moreover, technological convergence, where mass spectrometry is being integrated with other techniques like chromatography, thus expanding its applicability, is strengthening the market growth.
The recent technological advancements
The surge in technological advancements is significantly contributing to the expansion of the mass spectrometry market. Cutting-edge improvements, such as higher sensitivity, better accuracy, and rapid throughput are making these instruments indispensable in modern laboratories. Furthermore, technological progress is expanding the capabilities of mass spectrometry instruments to include the analysis of increasingly complex samples. Additionally, recent innovations like high-resolution mass spectrometry and tandem mass spectrometry that are providing unprecedented levels of detail and analytical depth are supporting the market growth. Moreover, the incorporation of real-time monitoring capabilities, allowing immediate data collection and interpretation, is strengthening the market growth. In addition, the miniaturization of mass spectrometry devices, leading to the creation of portable units that can be employed for on-site analysis, is favoring the market growth.
The imposition of strict regulatory policies for quality control
Regulatory requirements for quality control in industries, such as pharmaceuticals and food safety are propelling the mass spectrometry market growth. The introduction of stringent standards by regulatory agencies is prompting companies to rely on mass spectrometry for its high degree of accuracy and sensitivity in detecting impurities, ensuring product quality, and validating processes. In addition, mass spectrometry ensures that compounds meet purity standards and that contaminants are detected at extremely low concentrations. Furthermore, the widespread technology utilization in the food industry to ensure the absence of pesticides, toxins, and other contaminants is favoring the market growth. Moreover, these regulatory compulsions make mass spectrometry not just an option but a necessity for quality assurance in product development and manufacturing processes.
The growing focus on personalized medicine
The growing emphasis on personalized medicine is another pivotal factor stimulating the mass spectrometry market. Healthcare is becoming increasingly tailored to individual patients, resulting in a higher demand for detailed molecular and genetic information. Mass spectrometry provides the capability to analyze biomarkers, metabolites, and proteins at a molecular level, thereby playing a significant role in proteomics and genomics research. These insights are crucial for understanding individual health profiles, predicting disease susceptibility, and tailoring treatments accordingly. Furthermore, the rise in personalized medicine is pushing healthcare providers and research institutions to invest in mass spectrometry technologies to keep up with the demand for precise, patient-specific data. As a result, the focus on personalized healthcare is not only boosting the application of mass spectrometry in existing markets but is also pioneering its entry into new avenues of medical science.
IMARC Group provides an analysis of the key trends in each segment of the global mass spectrometry market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on technology and application.
Triple Quadrupole (Tandem)
Quadrupole TOF (Q-TOF)
FTMS (Fourier Transform Mass Spectrometry)
Quadrupole
Time-of-Flight (TOF)
ION Trap
Others
Triple quadrupole (tandem) dominates the market
The report has provided a detailed breakup and analysis of the market based on technology. This includes triple quadrupole (Tandem), quadrupole TOF (Q-TOF), FTMS (fourier transform mass spectrometry), quadrupole, time-of-flight (TOF), ION trap, and others. According to the report, triple quadrupole (tandem) represented the largest segment.
Triple quadrupole systems offer high sensitivity and selectivity, making them ideal for detecting low-abundance analytes in complex samples. Furthermore, they are versatile and can be applied to various fields, such as proteomics, metabolomics, pharmaceuticals, and environmental analysis. This multi-disciplinary application range contributes to their widespread adoption. Besides this, triple quadrupole mass spectrometers excel in quantitative measurements, as they provide excellent repeatability and accuracy, which are crucial in sectors like drug development and diagnostics. Additionally, these systems are often compatible with various ionization techniques and chromatography systems, allowing for broader applications and easier integration into existing workflows. Moreover, triple quadrupole meets or exceeds the stringent regulations and quality standards required in many industries, which makes them a safer investment for compliance-conscious organizations.
Pharmaceuticals
Biotechnology
Chemical and Petrochemicals
Environmental Testing
Food & Beverage Testing
Others
Pharmaceutical hold the largest share in the market
A detailed breakup and analysis of the market based on application has also been provided in the report. This includes pharmaceuticals, biotechnology, chemical and petrochemicals, environmental testing, food & beverage testing, and others. According to the report, pharmaceuticals represented the largest segment.
Pharmaceuticals are dominating the market as it is governed by strict regulatory standards. In line with this, mass spectrometry is invaluable for quality control and compliance, ensuring that pharmaceutical products meet these rigorous benchmarks. Furthermore, mass spectrometry is critical in the various stages of drug discovery, including target identification, screening, and pharmacokinetics. It provides accurate and precise data that aid researchers in the identification and quantification of compounds, thereby accelerating the time-to-market for new drugs. Besides this, mass spectrometry offers the high sensitivity and specificity required for proteomic and genomic studies, thereby driving its adoption in the pharmaceutical sector. Additionally, it is extensively used in metabolomics to identify and quantify metabolites, thus offering valuable insights into drug metabolism. Moreover, mass spectrometry is routinely used for quality control and batch-to-batch verification of raw materials, intermediates, and finished products.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest mass spectrometry market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America hosts some of the world's leading research institutions and laboratories, which contributes to a high demand for mass spectrometry equipment for advanced research. Additionally, various government agencies are offering substantial grants and funding options for research and development (R&D) activities, including those that require mass spectrometry, thus fostering a favorable environment for market growth. Besides this, North America is the headquarters for numerous companies that are market leaders in the mass spectrometry segment. Moreover, the region is at the forefront of technological innovation in advanced mass spectrometry techniques like time-of-flight (TOF) and orbitrap. In addition to this, the presence of a robust healthcare system, coupled with the focus on precision medicine and diagnostics in the region, is further boosting the market growth.
Top companies are developing new technologies and improving existing mass spectrometry techniques. This includes creating instruments that are faster, more sensitive, and easier to use. Furthermore, they are engaging in acquisitions and mergers to diversify their portfolio, enter into new markets, and strengthen their presence. Apart from this, leading players are partnering with research institutions, laboratories, or other firms to share expertise and resources, which enables them to bring products to market more quickly and to tackle problems from multiple angles. Besides this, companies are also working to ensure that their products meet strict regulatory standards, both locally and globally. It involves clinical trials, rigorous testing, and obtaining necessary certifications. Moreover, major players are offering robust customer service, including training programs to educate users on how to get the most out of their mass spectrometry equipment.
Agilent Technologies Inc.
Bruker
Danaher Corporation
JEOL Ltd.
Kore Technology Ltd.
LECO Corporation
PerkinElmer Inc.
Rigaku Corporation
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Waters Corporation
In June 2022, Agilent Technologies Inc. announced the launch of new quadrupole mass spectrometers at the ASMS conference on mass spectrometry and allied topics.
In June 2023, Bruker launched the timsTOF ultra mass spectrometer with transformative sensitivity.
In February 2021, JEOL announced the launch of new time-of-flight mass spectrometers with improved performance and functionality.